BRIEF published on 11/20/2025 at 10:05, 9 months 23 days ago Nabaltec AG Reports Stable Earnings Amid Revenue Dip in 2025 EBIT Margin Revenue Decline Q3 Results Nabaltec AG 2025 Earnings
PRESS RELEASE published on 11/20/2025 at 10:00, 9 months 23 days ago Nabaltec AG with continued solid earnings power and a slight decline in revenues in the third quarter of 2025 Nabaltec AG reports solid earnings with a slight revenue decline in Q3 2025. Revenue forecast adjusted for 2025 expecting a maximum 2% decrease compared to the previous year Forecast Revenue Decline Earnings Nabaltec AG Q3 2025
BRIEF published on 08/22/2025 at 09:05, 1 year ago Nabaltec AG Releases Q2 Figures, Maintains "Buy" Rating Gross Margin BUY Rating Nabaltec AG Q2 2025 Results Specialty Alumina
PRESS RELEASE published on 08/22/2025 at 09:00, 1 year ago Original-Research: Nabaltec AG (von NuWays AG): BUY NuWays AG releases a research update on Nabaltec AG, highlighting Q2 results and future prospects, recommending a BUY. Key points include demand trends, improved gross margin, and cash position NuWays AG Investment Recommendation Research Update Q2 Results Nabaltec AG
BRIEF published on 08/21/2025 at 10:05, 1 year ago Nabaltec AG Reports Decline in First Half of 2025 EBIT Margin Q2 Results Nabaltec AG Investment Plans 2025 Revenue
PRESS RELEASE published on 08/21/2025 at 10:00, 1 year ago Nabaltec AG publishes interim report January to June 2025 Nabaltec AG published its interim report January to June 2025, reporting a revenue decrease of 1.7% and EBIT margin of 8.4%. Forecast for 2025: Revenue decline of up to 2% with EBIT margin expected in the range of 7% to 9% EBIT Margin Forecast Revenue Decrease Interim Report Nabaltec AG
BRIEF published on 08/05/2025 at 09:05, 1 year 1 month ago Nabaltec AG Faces Sales Decline Yet Remains Promising Sales Decline Long-term Growth Nabaltec AG Foreign Exchange Aluminum Hydroxide
PRESS RELEASE published on 08/05/2025 at 09:00, 1 year 1 month ago Original-Research: Nabaltec AG (von NuWays AG): BUY Nabaltec AG lowers FY25 sales guidance due to FX effect and weaker demand, maintains FY EBIT margin guidance. Q2 sales decrease, but core product demand remains strong. Company offers low valuation and healthy balance sheet Valuation Nabaltec AG Q2 Sales FY25 Sales Guidance Core Product Demand
BRIEF published on 07/24/2025 at 13:44, 1 year 1 month ago Nabaltec AG Revises 2025 Revenue Forecast, Maintains Earnings Outlook EBIT Margin Currency Effects Nabaltec AG Market Uncertainty 2025 Revenue Forecast
PRESS RELEASE published on 07/24/2025 at 13:39, 1 year 1 month ago EQS-Adhoc: Nabaltec AG adjusts revenue forecast for Financial Year 2025 and confirms earnings forecast Nabaltec AG adjusts revenue forecast for Financial Year 2025 and confirms earnings forecast. Revenues expected to decrease by up to 2% due to currency effects and market uncertainty Revenue Forecast Earnings Forecast Currency Effects Nabaltec AG Financial Year 2025
Published on 09/12/2026 at 02:35, 1 day 20 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days 1 hour ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 6 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 day 5 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 15 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 2 days ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 days ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 2 days 3 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 16 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 3 hours ago Availability of the 2026 Interim Financial Report
